AFJK
Aimei Health Technology Co., LtdNASDAQFinancial Services$25.39-0.12%ClosedMarket Cap: $155.4M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
110.57
PEG
—
P/B
2.42
P/S
0.00
EV/EBITDA
343.71
DCF Value
$-0.02
FCF Yield
-0.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
2.9%
ROA
3.1%
ROIC
-2.2%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $0.00 | $352.0K | $0.06 |
| Q2 2025 | $0.00 | $425.0K | $0.07 |
| Q1 2025 | $0.00 | $184.7K | $0.02 |
| Q4 2024 | $0.00 | $444.1K | $0.05 |
Trading Activity
Insider Trades
View AllMIZUHO SECURITIES USA LLC10 percent owner
SellTue Feb 11
MIZUHO SECURITIES USA LLC10 percent owner
SellTue Feb 11
Company Info
Sector
Financial Services
Industry
—
Country
US
Exchange
NASDAQ
Beta
-1.50
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.